UK markets closed

CNS Pharmaceuticals, Inc. (CNSP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.2150+0.0060 (+2.87%)
At close: 04:00PM EDT
0.2153 +0.00 (+0.14%)
After hours: 06:10PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
7,847
14,096
9,300
9,805
5,062
Selling general and administrative
4,711
4,770
5,967
4,681
4,393
Total operating expenses
12,558
18,865
15,267
14,486
9,455
Operating income or loss
-12,558
-18,865
-15,267
-14,486
-9,455
Interest expense
6.953
13.805
7.027
9.285
3.264
Income before tax
-12,565
-18,851
-15,274
-14,495
-9,458
Income from continuing operations
-12,565
-18,851
-15,274
-14,495
-9,458
Net income
-12,565
-18,851
-15,274
-14,495
-9,458
Net income available to common shareholders
-12,565
-18,851
-15,274
-14,495
-9,458
Basic EPS
-7.60
-
-11.22
-16.50
-17.10
Diluted EPS
-7.60
-
-11.22
-16.50
-17.10
Basic average shares
2,867
-
1,362
878.443
553.948
Diluted average shares
2,867
-
1,362
878.443
553.948